The product is currently listed from $199.99 per pen, compared with BuyCanadianInsulin.com’s advertised starting price of ...

Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacare Holdings Limited ("Aspen"), today announced that Health Canada has approved ᴾʳAspen-Semaglutide, a generic equivalent of Ozempic® ...

SAO PAULO, May 26 (Reuters) - Brazil's health regulator Anvisa said on Tuesday it had approved EMS's Ozivy, the country's first semaglutide-based ‌injector pen, as the drugmaker looks to expand into a ...

Add Yahoo as a preferred source to see more of our stories on Google. Ozempic aids weight loss but scientists are investigating the other health benefits of the jab It seems as though Ozempic and ...

Semaglutide is the active ingredient in certain brand-name medications prescribed for obesity, type 2 diabetes, and more. Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Drugmaker Sun Pharmaceutical Industries has received the green signal from the South African Health Products Regulatory ...

The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg dose. Nearly half of participants lost 20% or more of their body weight, ...

Sun Pharma has received South African approval for its generic semaglutide injection, expanding access to affordable ...

The Medicines and Healthcare products Regulatory Agency (MHRA) on Tuesday approved Novo Nordisk's (NVO) new single-dose 7.2mg semaglutide (Wegovy) by pen to treat adult patients with obesity, who have ...

The generic semaglutide will be available as a pre-filled, multi-dose injectable pen in two strengths, 2 mg/1.5 mL and 4 mg/3 ...